GPT-Rosalind
GPT-Rosalind is a purpose-built frontier reasoning model developed by OpenAI to accelerate scientific research across biology, drug discovery, and translational medicine. It is designed specifically for life sciences workflows, where researchers must navigate large volumes of literature, experimental data, and specialized databases to generate and validate new ideas. It combines deep domain understanding in areas such as chemistry, genomics, protein engineering, and disease biology with advanced tool-use capabilities, allowing it to interact with scientific databases, analyze experimental outputs, and support complex, multi-step reasoning tasks. It can assist with evidence synthesis, hypothesis generation, literature review, sequence interpretation, and experimental planning, helping scientists move faster from raw data to actionable insights. GPT-Rosalind transforms complex, time-intensive research processes into more efficient AI-assisted workflows.
Learn more about GPT-Rosalind
Claude Science
Claude Science is an AI-powered scientific research application that helps researchers perform data analysis, literature review, computational workflows, and manuscript preparation within a single environment. Built on Claude models, the application integrates scientific databases, research tools, electronic lab notebooks, HPC systems, and domain-specific software to support end-to-end research workflows. It manages computational environments across local machines, Linux systems, and high-performance computing clusters while maintaining reproducible records of every analysis. Researchers can generate publication-quality figures, perform complex analyses, and trace every result back to the underlying code, environment, and conversation. Claude Science also supports specialized fields including genomics, proteomics, single-cell biology, structural biology, and cheminformatics through preconfigured scientific capabilities.
Learn more about Claude Science
SciSure
5.0 out of 5 stars
(4 Ratings)
SciSure helps scientific organizations replace fragmented, disconnected systems with a single governed platform for managing lab operations, so teams spend less time reconciling data across tools and more time on research. By combining Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and Health & Safety (EHS) capabilities in one system, SciSure improves reproducibility, strengthens visibility into day-to-day lab activity, and helps organizations reduce risk as they scale. Researchers document experiments, protocols, and results in a structured, searchable digital format with customizable templates and version control, replacing paper notebooks and scattered files. Samples are tracked from intake through processing, storage, and disposal, maintaining full lineage and chain-of-custody records alongside chemical and general lab inventory management and workflow automation. Health & Safety functionality is built into the same platform, covering chemical inventory alongside Safety Data Sheets (SDS), regulatory compliance workflows, and audit readiness, so labs don't need a separate system to stay compliant and audit-ready.
Labs can also extend the platform through an optional marketplace of add-ons, so they can bring in additional capability, like AI-powered support, automated data analysis, protocol generation, toxicity prediction, and image analysis, only where it adds value, without disrupting the rest of their workflow or committing to features they don't need. SciSure also connects directly to lab instruments, external databases, and third-party tools, so data moves between systems without manual re-entry.
SciSure supports both cloud and dedicated hosting, giving organizations control over the deployment model that fits their infrastructure, security, and compliance requirements. It's built to serve academic institutions, biopharma and biotech companies, and start-ups alike, with role-based support for scientists, lab operations staff, safety and compliance teams, leadership, and IT professionals, so the platform works the way each type of user actually needs it to.
Learn more about SciSure
BenevolentAI
BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.
Learn more about BenevolentAI